Caricamento...
Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: a single institution experience
KRAS mutation is an important predictive and prognostic factor for patients receiving anti-EGFR therapy. An expanded KRAS, NRAS, BRAF, PIK3CA mutation analysis provides additional prognostic information, but its role in predicting bevacizumab efficacy is unclear. T he aim of our study was to evaluat...
Salvato in:
| Pubblicato in: | Acta medica Lituanica |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Francês |
| Pubblicazione: |
Vilniaus Universitetas
2016
|
| Soggetti: | |
| Accesso online: | https://www.redalyc.org/articulo.oa?id=694073987006 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|